What's breaking now, across thousands of outlets.
Shionogi is buying an Austin, TX-based commercial biotech for $2 billion upfront, adding another medicine to the Japanese pharma's rare disease portfolio. The drugmaker is scooping up IntraBio and its oral treatment Aqneursa, Shionogi
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Top-Up Pharmacy has been adjudged Community Pharmacy Chain of the Year at the 2026 Pharma Excellence Awards organised by the Pharmaceutical Society of Ghana (PSGH).
A Hong Kong fertility clinic that had most of its services suspended for mishandling embryo biopsy specimens from two patients has been cleared to fully resume all treatments after implementing improvement measures.
Although unconfirmed reports suggest pneumonic plague, officials have not publicly identified the infection.
The Federal Government says it has established 10 radio-diagnostic centres across Nigeria and plans to establish a multi-specialty hospital in each of the country’s six geopolitical zones as part of…
Teenagers were 16 at the time of incident in Mullingar in which home-made shotgun was fired, houses were attacked and four cars set ablaze
Alector is teaming up with another large drugmaker, fresh off a separate partnership collapsing. Alector will get $100 million upfront from Roche in a deal centered on the biotech’s neuroscience and Parkinson’s disease efforts. If ...
